Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1179-1183
doi: 10.1161/hq0701.092135
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hattori, Y.
Right arrow Articles by Kasai, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hattori, Y.
Right arrow Articles by Kasai, K.
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Cell signalling/signal transduction
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1179.)
© 2001 American Heart Association, Inc.


Vascular Biology

4-Hydroxynonenal Prevents NO Production in Vascular Smooth Muscle Cells by Inhibiting Nuclear Factor-{kappa}B–Dependent Transcriptional Activation of Inducible NO Synthase

Yoshiyuki Hattori; Sachiko Hattori; Kikuo Kasai

From the Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi, Japan.

Correspondence to Dr Yoshiyuki Hattori, Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, Japan. E-mail yhattori{at}dokkyomed.ac.jp

Abstract—The role of lipid peroxidation products in atherogenesis was studied. We investigated whether 4-hydroxy-2-nonenal (HNE) modulates activation of the nuclear factor (NF)-{kappa}B system or alters expression of the NF-{kappa}B target gene product, inducible NO synthase (iNOS), in vascular smooth muscle cells (VSMCs) stimulated by lipopolysaccharide (LPS) in combination with interferon (IFN)-{gamma} (LPS/IFN). NO production induced by LPS/IFN was dose-dependently inhibited by HNE. NF-{kappa}B activation by LPS/IFN was inhibited by HNE in a dose-dependent manner. HNE significantly decreased LPS/IFN-stimulated proteolysis of I{kappa}B-{alpha}. iNOS promoter activity stimulated by LPS/IFN was also decreased by HNE dose-dependently. The treatment of VSMCs with LPS/IFN strongly stimulated iNOS mRNA and protein expression. The LPS/IFN-induced increases in iNOS mRNA and protein levels were dose-dependently decreased by HNE. Our data suggest that treatment with HNE blocks signaling events required for I{kappa}B-{alpha} degradation, thereby preventing NF-{kappa}B activation. Inhibition of NF-{kappa}B–regulated gene expression, especially modulation of NO production, may contribute to atherogenesis.


Key Words: 4-hydroxy-2-nonenal • nuclear factor-{kappa}B • nitric oxide • vascular smooth muscle cells




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
J. Delgado Alves, L. J. Mason, P. R. J. Ames, P. P. Chen, J. Rauch, J. S. Levine, R. Subang, and D. A. Isenberg
Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model
Rheumatology, October 1, 2005; 44(10): 1238 - 1244.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Monaco and E. Paleolog
Nuclear factor {kappa}B: a potential therapeutic target in atherosclerosis and thrombosis
Cardiovasc Res, March 1, 2004; 61(4): 671 - 682.
[Abstract] [Full Text] [PDF]